Issue 1, 2016
From the journal:

MedChemComm

Correction: Syntheses and biological evaluations of highly functionalized hydroxamate containing and N-methylthio monobactams as anti-tuberculosis and β-lactamase inhibitory agents

Mark W. Majewski,a   Kyle D. Watson,a   Sanghyun Cho,b   Patricia A. Miller,a   Scott G. Franzblaub  and  Marvin J. Miller*a  

* Corresponding authors

a Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, USA
E-mail: mmiller1@nd.edu
Fax: +1 574 631 6652
Tel: +1 574 631 7571

b Institute for Tuberculosis Research, College of Pharmacy, University of Illinois at Chicago, MIC 964, Rm. 412, IL 60612, USA

Abstract

Correction for ‘Syntheses and biological evaluations of highly functionalized hydroxamate containing and N-methylthio monobactams as anti-tuberculosis and β-lactamase inhibitory agents.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C5MD90052B
Article type
Correction
Submitted
28 Oct 2015
Accepted
28 Oct 2015
First published
06 Nov 2015
This article is Open Access
Creative Commons BY license

Med. Chem. Commun., 2016,7, 202-202

Permissions

Request permissions

Correction: Syntheses and biological evaluations of highly functionalized hydroxamate containing and N-methylthio monobactams as anti-tuberculosis and β-lactamase inhibitory agents

M. W. Majewski, K. D. Watson, S. Cho, P. A. Miller, S. G. Franzblau and M. J. Miller, Med. Chem. Commun., 2016, 7, 202 DOI: 10.1039/C5MD90052B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements